- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
ARCA Biopharma Inc
+ Add to WatchlistABIO:US
2.5100 USD 0.1700 7.26%As of 20:10:00 ET on 05/21/2013.
Snapshot for ARCA Biopharma Inc (ABIO)
| Open: | 2.3900 | Day's Range: | 2.3500 - 2.6000 | Volume: | 56,074 |
|---|---|---|---|---|---|
| Previous Close: | 2.3400 | 52wk Range: | 1.3800 - 5.9302 | 1-Yr Rtn: | -4.90% |
Key Statistics for ABIO
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -2.0400 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 8.00 |
| Shares Outstanding (M) | 3.19 |
| 30 Day Average Volume | 127,640 |
| Price/Book (mrq) | 1.9257 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ABIO
Company Profile & Key Executives for ABIO
Arca Biopharma, Inc. develops genetically targeted therapies for heart failure and other cardiovascular diseases.
| Michael R BristowPresident/CEO | Patrick M WheelerChief Financial Officer |
| Christopher D OzeroffSenior VP/Secretary/Gen Cnsl |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ABIO News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page